Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02425956 · ClinicalTrials.gov registry record · NA

Non-invasive Quantification of Liver Iron With MRI

A NA study, sponsored by GE Healthcare.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT02425956 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02425956, a NA study, has completed, sponsored by GE Healthcare.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

This study is being conducted to build a library of prospectively collected clinical data from subjects with iron overload examined with commercially available MRI devices. This data library is intended for use in future engineering development and other research activities, including future regulatory submissions.

Interventions

  • DEVICE GE Optima/Discovery® MRI data of the liver

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2015-04
Est. Completion 2016-06-30
Phase NA

Sponsor

GE Healthcare

99 total trials

What the Registry Record Tells You About NCT02425956

The ClinicalTrials.gov registry entry for NCT02425956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which GE Optima/Discovery® MRI data of the liver is the first listed.

NCT02425956 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02425956 about?

NCT02425956 is a clinical study titled "Non-invasive Quantification of Liver Iron With MRI". This study is being conducted to build a library of prospectively collected clinical data from subjects with iron overload examined with commercially available MRI devices. This data library is intended for use in future engineering development and other research activities, including future regulat...

What is the current status of trial NCT02425956?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2015-04. Estimated completion is 2016-06-30.

What interventions are being tested in trial NCT02425956?

The interventions under investigation include: GE Optima/Discovery® MRI data of the liver (DEVICE).

Who is sponsoring clinical trial NCT02425956?

This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.